These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 12702042)

  • 61. From bench to bedside to bug: an update of clinically relevant advances in the care of persons with Helicobacter pylori- associated diseases.
    Chiba N; Thomson AB; Sinclair P
    Can J Gastroenterol; 2000 Mar; 14(3):188-98. PubMed ID: 10758416
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Characteristics of gastric cancer in peptic ulcer patients with Helicobacter pylori infection.
    Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(16):4954-60. PubMed ID: 25945009
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Effect of rebamipide on Helicobacter pylori infection in patients with peptic ulcer.
    Nebiki H; Higuchi K; Arakawa T; Ando K; Uchida T; Ito H; Harihara S; Kuroki T; Kobayashi K
    Dig Dis Sci; 1998 Sep; 43(9 Suppl):203S-206S. PubMed ID: 9753251
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Successful eradication of Helicobacter pylori prevents relapse of peptic ulcer disease.
    Tomita T; Fukuda Y; Tamura K; Tanaka J; Hida N; Kosaka T; Hori K; Sakagami T; Satomi M; Shimoyama T
    Aliment Pharmacol Ther; 2002 Apr; 16 Suppl 2():204-9. PubMed ID: 11966543
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Healing peptic ulcer disease with therapy of Helicobacter pylori infection--an overview].
    Leodolter A; Peitz U; Malfertheiner P
    Wien Med Wochenschr; 2001; 151(13-14):300-8. PubMed ID: 11582994
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Differences between generalist and specialist physicians regarding Helicobacter pylori and peptic ulcer disease.
    Fendrick AM; Hirth RA; Chernew ME
    Am J Gastroenterol; 1996 Aug; 91(8):1544-8. PubMed ID: 8759658
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.
    Ford A; Delaney B; Forman D; Moayyedi P
    Cochrane Database Syst Rev; 2003; (4):CD003840. PubMed ID: 14583996
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Helicobacter pylori: from bench to bedside.
    Chiba N; Matisko A; Sinclair P; Thomson AB
    Can J Gastroenterol; 1997 Oct; 11(7):589-96. PubMed ID: 9395760
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A new highly effective short-term therapy schedule for Helicobacter pylori eradication.
    Zullo A; Rinaldi V; Winn S; Meddi P; Lionetti R; Hassan C; Ripani C; Tomaselli G; Attili AF
    Aliment Pharmacol Ther; 2000 Jun; 14(6):715-8. PubMed ID: 10848654
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Lansoprazole triple therapy for Helicobacter pylori--is 5 days enough?
    O'Connor HJ; McLoughlin R; Kelly S; Laundon J; Cunnane K
    Aliment Pharmacol Ther; 1998 Mar; 12(3):273-6. PubMed ID: 9570262
    [TBL] [Abstract][Full Text] [Related]  

  • 71. High cure rate of Helicobacter pylori infection using tripotassium dicitrato bismuthate, furazolidone and clarithromycin triple therapy for 1 week.
    Xiao SD; Liu WZ; Hu PJ; Xia DH; Tytgat GN
    Aliment Pharmacol Ther; 1999 Mar; 13(3):311-5. PubMed ID: 10102963
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Management of peptic ulcers: emerging issues.
    Freston JW
    World J Surg; 2000 Mar; 24(3):250-5. PubMed ID: 10658056
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Evaluation of therapeutic regimens for the treatment of Helicobacter pylori infection.
    Lee DH; Park HJ; Song SY; Lee SJ; Choi W; Lee YC; Chung JB; Kang JK; Park IS; Lee YH; Kim HK
    Yonsei Med J; 1996 Aug; 37(4):270-7. PubMed ID: 8942297
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Follow-up survey of a large-scale multicenter, double-blind study of triple therapy with lansoprazole, amoxicillin, and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients.
    Asaka M; Kato M; Sugiyama T; Satoh K; Kuwayama H; Fukuda Y; Fujioka T; Takemoto T; Kimura K; Shimoyama T; Shimizu K; Kobayashi S;
    J Gastroenterol; 2003; 38(4):339-47. PubMed ID: 12743773
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences.
    Ofman JJ; Etchason J; Fullerton S; Kahn KL; Soll AH
    Ann Intern Med; 1997 Feb; 126(4):280-91. PubMed ID: 9036800
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Metronidazole, ranitidine and clarithromycin combination for treatment of Helicobacter pylori infection (modified Bazzoli's triple therapy).
    Yousfi MM; El-Zimaity HM; Cole RA; Genta RM; Graham DY
    Aliment Pharmacol Ther; 1996 Feb; 10(1):119-22. PubMed ID: 8871452
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Survey of general practitioners' knowledge about Helicobacter pylori infection.
    Canbaz S; Sunter AT; Peksen Y; Leblebicioglu H
    BMC Gastroenterol; 2005 Jan; 5():4. PubMed ID: 15673470
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Application of Maastricht 2-2000 guidelines for the management of Helicobacter pylori among specialists and primary care physicians in israel: are we missing the malignant potential of Helicobacter pylori?
    Shirin H; Birkenfeld S; Shevah O; Levine A; Epstein J; Boaz M; Niv Y; Avni Y
    J Clin Gastroenterol; 2004 Apr; 38(4):322-5. PubMed ID: 15087690
    [TBL] [Abstract][Full Text] [Related]  

  • 79. An etiologic approach to management of duodenal and gastric ulcers.
    Rex DK
    J Fam Pract; 1994 Jan; 38(1):60-7. PubMed ID: 8289053
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ulcers and gastritis.
    Kashiwagi H
    Endoscopy; 2005 Feb; 37(2):110-5. PubMed ID: 15692925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.